Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dobianer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Medicine|February 23, 2011
Quantitative PCR Detection of c-erbB-2 Gene AmplificationK Dobianer, M Medl, J Spona
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|September 1, 1993
Inhibition of ovulation by a triphasic gestodene-containing oral contraceptiveJ Spona, U Lachnit-Fixson, B Düsterberg, et al.
Anticancer Research|June 6, 1998
Detection of oestrogen and progesterone receptor expression in breast tumors by semiquantitative PCRT Hackl, M Zickl, K Dobianer, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 1, 1994
Clinical therapy and HER-2 oncogene amplification in breast cancer: chemo- vs radiotherapyM Stühlinger, H Helmer, K Dobianer, et al.
Gynecologic Oncology|February 1, 1995
HER-2 amplification but not butyrylcholinesterase multability reflects aggressiveness of European-originated ovarian tumorsK Dobianer, C Hruza, G Ehrlich, et al.
European Journal of Pediatrics|August 1, 1994
Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutationJ Larsen, S Campbell, E B Faragher, et al.
Gynecologic Oncology|December 1, 1995
DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancerM Medl, P Sevelda, K Czerwenka, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samplesC Hruza, K Dobianer, A Beck, et al.
British Journal of Cancer|May 1, 1993
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancerA Rosen, P Sevelda, M Klein, et al.
Oncology|September 1, 1995
HER-2 oncogene is not amplified in primary carcinoma of the fallopian tube. Austrian Cooperative Study Group for Fallopian Tube CarcinomaM Stühlinger, A C Rosen, K Dobianer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Medicine|February 23, 2011
Quantitative PCR Detection of c-erbB-2 Gene AmplificationK Dobianer, M Medl, J Spona
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|September 1, 1993
Inhibition of ovulation by a triphasic gestodene-containing oral contraceptiveJ Spona, U Lachnit-Fixson, B Düsterberg, et al.
Anticancer Research|June 6, 1998
Detection of oestrogen and progesterone receptor expression in breast tumors by semiquantitative PCRT Hackl, M Zickl, K Dobianer, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 1, 1994
Clinical therapy and HER-2 oncogene amplification in breast cancer: chemo- vs radiotherapyM Stühlinger, H Helmer, K Dobianer, et al.
Gynecologic Oncology|February 1, 1995
HER-2 amplification but not butyrylcholinesterase multability reflects aggressiveness of European-originated ovarian tumorsK Dobianer, C Hruza, G Ehrlich, et al.
European Journal of Pediatrics|August 1, 1994
Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutationJ Larsen, S Campbell, E B Faragher, et al.
Gynecologic Oncology|December 1, 1995
DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancerM Medl, P Sevelda, K Czerwenka, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samplesC Hruza, K Dobianer, A Beck, et al.
British Journal of Cancer|May 1, 1993
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancerA Rosen, P Sevelda, M Klein, et al.
Oncology|September 1, 1995
HER-2 oncogene is not amplified in primary carcinoma of the fallopian tube. Austrian Cooperative Study Group for Fallopian Tube CarcinomaM Stühlinger, A C Rosen, K Dobianer, et al.
Pageof 1